Cornercap Investment Counsel’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-101,039
Closed -$151K 666
2023
Q3
$151K Sell
101,039
-1,198
-1% -$2.28K 0.03% 512
2023
Q2
$233K Sell
102,237
-63,163
-38% -$145K 0.04% 491
2023
Q1
$324K Sell
165,400
-318
-0.2% -$659 0.06% 463
2022
Q4
$272K Buy
165,718
+83,888
+103% +$131K 0.05% 476
2022
Q3
$163K Buy
81,830
+29,690
+57% +$71K 0.03% 512
2022
Q2
$113K Buy
+52,140
New +$177K 0.02% 527

Other funds holding LIAN

Cornercap Investment Counsel's LIAN Position: Q4 2023 in Review

Cornercap Investment Counsel sold out of LianBio American Depositary Shares (LIAN) in Q4 2023, closing a stake of 101,039 shares — an estimated $151K sold.

Cornercap Investment Counsel first reported a position in LIAN in Q2 2022 and held it in 6 quarters. The position peaked at $324K in Q1 2023. 29 funds tracked by Wall St. Rank hold LIAN as of Q4 2023.

  • Cornercap Investment Counsel reported no remaining LianBio American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 101,039 LianBio American Depositary Shares shares in Q4 2023, an estimated $151K.
  • Cornercap Investment Counsel first reported a position in LianBio American Depositary Shares in Q2 2022 and held it in 6 quarters.
  • Cornercap Investment Counsel's LianBio American Depositary Shares position peaked at $324K in Q1 2023.
  • 29 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2023.

Based on Cornercap Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.